Advertisement
Screener

Virax Biolabs Group Ltd (VRAX) Form 6-K: Report of foreign private issuer

Virax Biolabs Group Ltd Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-04: Form 6-K; Period of report 2026-09-04; Description 6-K; Document 6-k_atm_sticker_suppleme.htm.
  • 2026-08-26: Form 6-K; Period of report 2026-08-21; Description 6-K; Document 6-k_8.21.26_eagm_results.htm.
  • 2026-08-18: Form 6-K; Period of report 2026-08-18; Description 6-K; Document 6-k_q3_investor_deck.htm.
  • 2026-07-31: Form 6-K; Period of report 2026-07-31; Description 6-K; Document 6-k_special_meeting_auth.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-046-K2026-09-046-K6-k_atm_sticker_suppleme.htm
2026-08-266-K2026-08-216-K6-k_8.21.26_eagm_results.htm
2026-08-186-K2026-08-186-K6-k_q3_investor_deck.htm
2026-07-316-K2026-07-316-K6-k_special_meeting_auth.htm
2026-07-166-K2026-07-166-K6-k_7.16.26_shareholder_.htm
2026-07-106-K2026-07-106-K6-k_july_warrant_inducem.htm
2026-07-096-K2026-07-096-K6-k_7.9.26_fosun.htm
2026-06-246-K2026-06-246-K6-k_reverse_split_2026.htm
2026-06-126-K2026-06-126-K6-k_2026_eagm_results.htm
2026-05-266-K2026-05-266-K6-k_5.26.26_data_webinar.htm
2026-05-226-K2026-05-226-K6-k_special_meeting_may_.htm
2026-04-146-K2026-04-146-K6-k_4.14.26_shareholder_.htm
2026-04-106-K2026-04-106-K6-k_armistice_full_pfw_e.htm
2026-03-186-K2026-03-186-K6-k_2025_agm_results.htm
2026-01-306-K2026-01-306-K6-k_proxy_fy2025.htm
2025-12-046-K2025-12-046-K6-k_dec_2025_pipe.htm
2025-12-026-K2025-12-026-K6-k_fy2026_q2_results.htm
2025-07-306-K2025-07-306-K6-k_director_change_ian.htm
2025-06-136-K2025-06-136-K6-k_cfo_resignation.htm
2025-03-186-K2025-03-186-K6-k_clinical_study_enrol.htm
2025-03-136-K2025-03-136-K6-k_davo_poster_presenta.htm
2025-03-056-K2025-03-056-K6-k_davos_conference.htm
2025-02-256-K2025-02-256-K6-k_dhhs_align_pr.htm
2024-12-236-K2024-12-236-K6-k_2024_agm_results.htm
2024-12-176-K2024-12-176-K6-k_shareholder_letter_d.htm
2024-12-106-K2024-12-106-K6-k_tebubio_distribution.htm
2024-11-206-K2024-11-206-K6-k_fy2025_q2_results.htm
2024-10-316-K2024-10-316-K6-k_proxy_fy2024.htm
2024-10-236-K2024-10-236-K6-k_europa_biosite_distr.htm
2024-09-306-K2024-09-306-K6-k_atm_september_2024.htm
2024-08-236-K2024-08-236-K6-k_registered_direct_au.htm
2024-06-116-K2024-06-116-K6-k_director_change_nige.htm
2024-04-256-K2024-04-256-K6-k_escmid_product_launc.htm
2024-04-166-K2024-04-166-K6-k_escmid_2024.htm
2024-03-156-K2024-03-156-K6-k_nasdaq_deficiency.htm
2024-01-226-K2024-01-226-K6-k_atm.htm
2024-01-126-K2024-01-116-K6-k_fy2024_q2_results.htm
2023-12-216-K2023-12-216-K6-k_manchester_colab.htm
2023-12-206-K2023-12-206-K6-k_split_and_articles.htm
2023-12-186-K2023-12-186-K6-k_letter_from_ceo_dec_.htm
2023-12-146-K2023-12-146-K6-k_press_release_share_.htm
2023-12-086-K2023-12-086-K6-k_2023_agm_results.htm
2023-11-086-K2023-11-086-K6-k_proxy_fy2023.htm
2023-10-316-K2023-10-316-K6-k_clawback_policy.htm
2023-10-126-K2023-10-126-K6-k_armistice_warrant_de.htm
2023-10-046-K2023-10-046-K6-k_home_country_practic.htm
2023-09-126-K2023-09-126-K6-k_webinar_1.htm
2023-09-016-K2023-09-016-K6-k_coo_change.htm
2023-08-036-K2023-08-036-K6-k_nasdaq_180_day_exten.htm
2023-07-186-K2023-07-186-K6-k_new_laboratory.htm
2023-06-146-K2023-06-146-K6-k_shareholder_letter_6.htm
2023-05-046-K2023-05-046-K6-k_dubai_science_park.htm
2023-04-216-K2023-04-216-K6-k_reliant_auditor.htm
2023-04-196-K2023-04-196-K6-k_marburg.htm
2023-03-106-K2023-03-106-K6-k_pipe_03.08.23.htm
2023-03-076-K2023-03-076-K6-k_avian_flu.htm
2023-02-076-K2023-02-076-K6-k_cosmos_c19_ab.htm
2023-02-026-K2023-02-026-K6-k_q2_financial_results.htm
2023-02-026-K2023-02-026-K6-k_shareholder_letter_2.htm
2023-01-046-K2023-01-046-K6-k_hpv_test_kit_1.4.23.htm
2022-12-066-K2022-12-066-K6-k_eua_covid_12.05.22.htm
2022-11-186-K2022-11-186-K6-k_nelson_haight_11.17.htm
2022-11-156-K2022-11-156-K6-k_richard_pallin_11.15.htm
2022-11-086-K2022-11-086-K6-k_pr_pipe_11.04.22.htm
2022-11-036-K2022-11-036-K6-k_triple_test_11.03.22.htm
2022-10-266-K2022-10-266-K6-k_analytic_perf_10.25.htm
2022-09-226-K2022-09-226-K6-k_cosmos_9.22.22.htm
2022-09-206-K2022-09-206-K6-k_monkeypox_antigen_9.htm
2022-09-126-K2022-09-126-Khcw_conference_9.12.22.htm
2022-09-076-K2022-09-076-Khcw_conference_9.6.22.htm
2022-07-296-K2022-07-296-Kvrax_6k_uw_consumation.htm
2022-07-266-K2022-07-266-Kvrax_6k_no_xbrl.htm